| Record 13410 View: Standard | Glossary HistCite Guide |
|
Author(s): Leyssen P; De Clercq E; Neyts J
Title: Molecular strategies to inhibit the replication of RNA viruses
Source: ANTIVIRAL RESEARCH 78 (1): 9-25
Date: 2008 APR
Document Type: Journal : Review
DOI:
Language: English
Comment:
Address: Catholic Univ Louvain, Rega Inst Med Res, B-3000 Louvain, Belgium.
Reprint: Neyts, J, Catholic Univ Louvain, Rega Inst Med Res, Minderbroedersstr
10, B-3000 Louvain, Belgium. E-mail: johan.neyts@rega.kuleuven.be
Abstract: There are virtually no antiviral drugs available for the treatment of infections with RNA viruses. This is particularly worrisome since most of the highly pathogenic and emerging viruses are, and will likely continue to be, RNA viruses. These viruses can cause acute, severe illness, including severe respiratory disease, hemorrhagic fever and encephalitis, with a high case fatality rate. It is important to have potent and safe drugs at hand that can be used for the treatment or prophylaxis of such infections. Drugs approved for the treatment of RNA virus infections (other than HIV) are the influenza M2 channel inhibitors, amantadine and rimantadine; the influenza neuraminidase inhibitors, oseltamivir and zanamivir, and ribavirin for the treatment of infections with respiratory syncytial virus and hepatitis C virus. The molecular mechanism(s) by which ribavirin inhibits viral replication, such as depletion of intracellular GTP pools and induction of error catastrophe, may not readily allow the design of analogues that are more potent/selective than the parent drug. Highly pathogenic RNA viruses belong to a variety of virus families, each having a particular replication strategy, thus offering a wealth of potential targets to selectively inhibit viral replication. We here provide a non-exhaustive review of potential experimental strategies, using small molecules, to inhibit the replication of several RNA viruses. Other approaches, such as the use of interferon or other host-response modifiers, immune serum or neutralizing antibodies, are not addressed in this review. (C) 2008 Elsevier B.V. All rights reserved.
Cited References: ABDELMAGID AF, 2001, CURR OPIN DRUG DISC, V4, P776 AIRAKSINEN A, 2003, VIROLOGY, V311, P339 ANAND K, 2003, SCIENCE, V300, P1763 ANDREI G, 1990, ANTIVIR RES, V14, P287 ANDREI G, 1993, ANTIVIR RES, V22, P45 ASAHINA Y, 2005, J HEPATOL, V43, P623 BAGINSKI SG, 2000, P NATL ACAD SCI USA, V97, P7981 BALZARINI J, 1993, J BIOL CHEM, V268, P24591 BALZARINI J, 2007, ANTIVIR CHEM CHEMOTH, V18, P1 BALZARINI J, 2007, J VIROL, V81, P362 BALZARINI J, 2007, NAT REV MICROBIOL, V5, P583 BARNARD DL, 2006, ANTIVIR RES, V71, P53 BAUSCH DG, 2008, ANTIVIR RES, V78, P150 BEIGEL J, 2008, ANTIVIR RES, V78, P91 BENARROCH D, 2004, J BIOL CHEM, V279, P35638 BINFORD SL, 2005, ANTIMICROB AGENTS CH, V49, P619 BINFORD SL, 2007, ANTIMICROB AGENTS CH, V51, P4366 BOLKEN TC, 2006, ANTIVIR RES, V69, P86 BOROWSKI P, 2007, ANTIVIR CHEM CHEMOTH, V18, P103 BOSSI P, 2004, EUR SURVEILL, V9, PE11 BOUGIE I, 2003, J BIOL CHEM, V278, P52471 BOUGIE I, 2004, J BIOL CHEM, V279, P22124 BRAY M, 2000, ANTIVIR RES, V45, P135 BRAY M, 2002, ANTIVIR RES, V55, P151 BRAY M, 2008, ANTIVIR RES, V78, P1 BRIGHT RA, 2005, LANCET, V366, P1175 BRIOLANT S, 2004, ANTIVIR RES, V61, P111 CARTER WA, 1974, SCIENCE, V186, P1172 CHAPMAN J, 2007, ANTIMICROB AGENTS CH, V51, P3346 CHAPMAN LE, 1999, ANTIVIR THER, V4, P211 CHEVALIEZ S, 2007, J VIROL, V81, P7732 CHEVALIEZ S, 2007, WORLD J GASTROENTERO, V13, P2461 CHONG HT, 2001, ANN NEUROL, V49, P810 COELMONT L, 2007, ANTIVIR RES, V74, PA39 CROTTY S, 2000, NAT MED, V6, P1375 CROTTY S, 2001, P NATL ACAD SCI USA, V98, P6895 DAVIES WL, 1964, SCIENCE, V144, P862 DECLERCQ E, 1990, BIOCHEM PHARMACOL, V39, P319 DECLERCQ E, 1991, BIOCHEM PHARMACOL, V41, P1821 DECLERCQ E, 2005, ANTIVIR RES, V67, P56 DECLERCQ E, 2006, NAT REV DRUG DISCOV, V5, P1015 DEFRANCESCO R, 2005, NATURE, V436, P953 DENG T, 2005, J VIROL, V79, P8669 DEPALMA AM, 2007, BIOCHEM BIOPH RES CO, V353, P628 DEPALMA AM, IN PRESS J VIROL DEPALMA AM, UNPUB SELECTIVE INHI DIXIT NM, 2004, NATURE, V432, P922 DOUGLAS JL, 2003, J VIROL, V77, P5054 DOUGLAS JL, 2005, ANTIMICROB AGENTS CH, V49, P2460 DVORETSKAIA I, 1991, VOP VIRUSOL+, V36, P55 DWEK RA, 2002, NAT REV DRUG DISCOV, V1, P65 DWYER JJ, 2007, P NATL ACAD SCI USA, V104, P12772 EGLOFF MP, 2002, EMBO J, V21, P2757 EGLOFF MP, 2007, J MOL BIOL, V372, P723 ENRIA DA, 2008, ANTIVIR RES, V78, P132 ERGONUL O, 2008, ANTIVIR RES, V78, P125 ERIKSSON B, 1977, ANTIMICROB AGENTS CH, V11, P946 FANG C, 2003, J APPL TOXICOL, V23, P453 FISHERHOCH SP, 1995, LANCET, V346, P472 FORESTIER N, 2007, HEPATOLOGY, V46, P640 FRICK DN, 2007, CURR ISSUES MOL BIOL, V9, P1 FURUTA Y, 2002, ANTIMICROB AGENTS CH, V46, P977 FURUTA Y, 2005, ANTIMICROB AGENTS CH, V49, P981 GAN L, 2003, BIOCHEMISTRY-US, V42, P857 GANESH VK, 2005, BIOORGAN MED CHEM, V13, P257 GEORGESCOURBOT MC, 2006, ANTIMICROB AGENTS CH, V50, P1768 GORIS N, 2007, ANTIVIR RES, V73, P161 GORIS N, 2008, ANTIVIR RES, V78, P170 GOSWAMI BB, 1979, BIOCHEM BIOPH RES CO, V89, P830 GOULD EA, 2008, ANTIVIR RES, V78, P140 GOWEN BB, 2007, ANTIMICROB AGENTS CH, V51, P3168 GOWEN BB, 2008, ANTIVIR RES, V78, P79 GRACI JD, 2006, REV MED VIROL, V16, P37 GREBER UF, 2005, CURR TOP MICROBIOL I, V285, P109 GUNTHER S, 2004, ANTIVIR RES, V63, P209 HE GM, 2008, ANTIVIR RES, V77, P72 HOLBROOK MR, 2008, ANTIVIR RES, V78, P69 HORIMOTO T, 2005, NAT REV MICROBIOL, V3, P591 HOSOYA M, 1989, ANTIVIR RES, V12, P87 HUFFMAN JH, 1973, ANTIMICROB AGENTS CH, V3, P235 HUGGINS J, 1999, J INFECT DIS S1, V179, PS240 HUGGINS JW, 1984, ANTIMICROB AGENTS CH, V26, P476 HUGGINS JW, 1989, REV INFECT DIS S4, V11, PS750 HUGGINS JW, 1991, J INFECT DIS, V164, P1119 JAHRLING PB, 1980, J INFECT DIS, V141, P580 JOHNSON S, 1997, J INFECT DIS, V176, P1215 JONSSON CB, 2008, ANTIVIR RES, V78, P162 JUBIN R, 2003, CURR OPIN INVEST DR, V4, P162 KAWANA F, 1987, ANTIMICROB AGENTS CH, V31, P1225 KHAN SH, 2008, ANTIVIR RES, V78, P103 KIM CU, 1997, J AM CHEM SOC, V119, P681 KLUMPP K, 2006, J BIOL CHEM, V281, P3793 LAMARRE D, 2003, NATURE, V426, P186 LANFORD RE, 2001, J VIROL, V75, P8074 LEYSSEN P, 2005, J VIROL, V79, P1943 LEYSSEN P, 2006, MOL PHARMACOL, V69, P1461 LIN CC, 2006, ANTIMICROB AGENTS CH, V50, P2368 LUTCHMAN GA, 2004, HEPATOLOGY S1, V40, PA385 LUZHKOV VB, 2007, BIOORGAN MED CHEM, V15, P7795 MAAG D, 2001, J BIOL CHEM, V276, P46094 MALAKHOV MP, 2006, ANTIMICROB AGENTS CH, V50, P1470 MALINOSKI F, 1981, VIROLOGY, V110, P281 MARDANI M, 2003, CLIN INFECT DIS, V36, P1613 MARKLAND W, 2000, ANTIMICROB AGENTS CH, V44, P859 MARQUEZ VE, 1988, J MED CHEM, V31, P1687 MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20 MCKEE KT, 1988, ANTIMICROB AGENTS CH, V32, P1304 MERTZ GJ, 2004, CLIN INFECT DIS, V39, P1307 MONATH TP, 2008, ANTIVIR RES, V78, P116 MONTGOMERY JA, 1982, J MED CHEM, V25, P626 MONTO AS, 2003, VACCINE, V21, P1796 MOSCONA A, 2005, J CLIN INVEST, V115, P1688 MOSCONA A, 2005, NEW ENGL J MED, V353, P1363 MURTHY HMK, 2000, J MOL BIOL, V301, P759 NAKA K, 2005, BIOCHEM BIOPH RES CO, V330, P871 NAKAGAWA M, 2004, BIOCHEM BIOPH RES CO, V313, P42 NAKAGAWA M, 2005, GASTROENTEROLOGY, V129, P1031 NEYTS J, 1996, ANTIVIR RES, V30, P125 PAESHUYSE J, 2006, HEPATOLOGY, V43, P761 PAESHUYSE J, 2006, J VIROL, V80, P149 PAESHUYSE J, 2007, J VIROL, V81, P11046 PATICK AK, 2005, ANTIMICROB AGENTS CH, V49, P2267 PATICK AK, 2006, ANTIVIR RES, V71, P391 PAUSE A, 2003, J BIOL CHEM, V278, P20374 PAWLOTSKY JM, 2004, GASTROENTEROLOGY, V126, P703 PAWLOTSKY JM, 2004, J HEPATOL S1, V40, P23 PFEIFFER JK, 2003, P NATL ACAD SCI USA, V100, P7289 POROTTO M, 2006, J VIROL, V80, P9837 RADA B, 1977, ANN NY ACAD SCI, V284, P410 RANKIN JT, 1989, VIROLOGY, V168, P147 RICE CM, 2005, HEPATOLOGY, V42, P1455 RUSSELL RJ, 2006, NATURE, V443, P45 SAIJO M, 2005, ANTIVIR RES, V66, P159 SCHEIDEL LM, 1991, VIROLOGY, V181, P490 SCHINKEL J, 2003, ANTIVIR THER, V8, P535 SCHMITZ H, 2002, MICROBES INFECT, V4, P43 SEVERSON WE, 2003, J VIROL, V77, P481 SHANNON WM, 1981, ANTIMICROB AGENTS CH, V20, P769 SHIGETA S, 1988, ANTIMICROB AGENTS CH, V32, P906 SIDWELL RW, 1973, ANTIMICROB AGENTS CH, V3, P242 SIDWELL RW, 2005, ANTIVIR RES, V68, P10 SIDWELL RW, 2007, ANTIMICROB AGENTS CH, V51, P845 SNELL NJC, 2004, J VIROL, V78, P10211 SPURGERS KB, 2008, ANTIVIR RES, V78, P26 STEPHEN EL, 1979, LANCET, V1, P268 STOCKMAN LJ, 2006, PLOS MED, V3, P1525, ARE343 STREETER DG, 1973, P NATL ACAD SCI USA, V70, P1174 STUYVER LJ, 2002, ANTIVIR CHEM CHEMOTH, V13, P345 TAKAHASHI K, 2003, ANTIVIR CHEM CHEMOTH, V14, P235 TAM RC, 1999, J HEPATOL, V30, P376 TAM RC, 2000, ANTIMICROB AGENTS CH, V44, P1276 TISDALE M, 1995, ANTIMICROB AGENTS CH, V39, P2454 TOMASSINI JE, 1996, ANTIMICROB AGENTS CH, V40, P1189 UJJINAMATADA RK, 2007, BIOORG MED CHEM LETT, V17, P2285 VANDERMEER FJUM, 2007, J ANTIMICROB CHEMOTH, V60, P741 VENTRE K, 2007, COCHRANE DB SYST REV, V24 VONITZSTEIN M, 1993, NATURE, V363, P418 WATASHI K, 2005, MOL CELL, V19, P111 WATTS DM, 1989, AM J TROP MED HYG, V41, P581 WU JZ, 2006, ANTIVIR CHEM CHEMOTH, V17, P33 WU SF, 2002, J VIROL, V76, P3596 YAN Z, 2006, J STRUCT BIOL, V155, P162 YANAGIDA K, 2004, ANTIVIR RES, V64, P195 YANG HT, 2003, P NATL ACAD SCI USA, V100, P13190 YANG HT, 2005, PLOS BIOL, V3, P1742 |